MedPath

PREZCOBIX

PREZCOBIX

Approved
DIN Number

02426501

Drug Class

Human

Market Date

Aug 28, 2014

Company
HC

Janssen Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02426501
AIG Number0255810001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AR14 DARUNAVIR AND COBICISTAT
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

COBICISTATActive
Strength: 150 MG
Monograph: COBICISTAT
DARUNAVIR (DARUNAVIR ETHANOLATE)Active
Strength: 800 MG
Monograph: DARUNAVIR (DARUNAVIR ETHANOLATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.